Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jeff C. Jerman
Observed names:
Jeff C Jerman,
Jeff Jerman,
Jeffery C Jerman
Institution:
LifeArc
Observed institutions:
LifeArc,
GlaxoSmithKline (United Kingdom),
University of Glasgow,
Medical Research Council
OpenAlex ID:
A5110005742
Activation of TRPV4 Channels (hVRL-2/mTRP12) by Phorbol Derivatives
2002
·
Hiroyuki Watanabe
, John B. Davis
, et al.
·
Journal of Biological Chemistry
·
605
PDF
Anandamide: an endogenous activator of the vanilloid receptor
2000
·
Darren Smart
, Jeffery C Jerman
·
Trends in Pharmacological Sciences
·
105
Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement
2001
·
Mark S. Duxon
, Jennifer Stretton
, et al.
·
Psychopharmacology
·
95
The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy
2014
·
Conor McCloskey
, Cara Rada
, et al.
·
EMBO Molecular Medicine
·
65
Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus
2004
·
Ellen M. Soffin
, Catherine H. Gill
, et al.
·
Neuropharmacology
·
55
ACTH Antagonists
2016
·
Adrian John Clark
, Rachel Forfar
, et al.
·
Frontiers in Endocrinology
·
49
PDF
High-Throughput Identification and Characterization of Novel, Species-selective GPR35 Agonists
2012
·
Zaynab Neetoo-Isseljee
, Amanda E. MacKenzie
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
40
Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK
2013
·
Paul D. Wright
, Gregory Weir
, et al.
·
Biochemical and Biophysical Research Communications
·
38
7TM pharmacology measured by label-free: a holistic approach to cell signalling
2009
·
Magalie Rocheville
, Jeff C Jerman
·
Current Opinion in Pharmacology
·
37
Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2
2019
·
Paul D. Wright
, David McCoull
, et al.
·
Biochemical and Biophysical Research Communications
·
24
PDF
Mining the Potential of Label-Free Biosensors for Seven-Transmembrane Receptor Drug Discovery
2013
·
Magalie Rocheville
, Julio Martin
, et al.
·
Progress in molecular biology and translational science
·
23
Identification of a novel specific small-molecule melanocortin-2-receptor antagonist
2022
·
Rachel Forfar
, Mashal Hussain
, et al.
·
Endocrine Connections
·
12
PDF
The novel anticonvulsant SB 204269 binds to a stereospecific site in the mouse brain
1996
·
Hugh Herdon
, Jeff Jerman
, et al.
·
European Journal of Pharmacology
·
10
Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle
1999
·
Andrew D Medhurst
, Warren D Hirst
, et al.
·
British Journal of Pharmacology
·
9
PDF
Investigating the potential of GalR2 as a drug target for neuropathic pain
2022
·
Kirsty Rich
, Samrina Rehman
, et al.
·
Neuropeptides
·
8
PDF
Identification and characterisation of a small-molecule ACTH receptor/Melanocortin-2-receptor antagonist
2018
·
Li Chan
, Mashal Hussain
, et al.
·
Endocrine Abstracts
Identification of ACTH/Melanocortin 2 receptor (MC2) antagonists
2015
·
Jeff Jerman
The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy
2014
·
Conor McCloskey
, Cara Rada
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Novel and potent GPR35 agonists aid identification of residues important in ligand interaction
2013
·
Amanda Elaine Mackenzie
, Zaynab Neetoo‐Isseljee
, et al.
·
The FASEB Journal
Show more works
View as search
Works count:
19
Citation count:
1,175
H-index:
12
I10-index:
13
Year
Topic
Type